In this study HLA-DQA1 and TNF genes in addition to HLA-DQB1 gene were investigated at DNA level for elucidation of the genetic backgrounds of Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. DNA, amplified by polymerase chain reaction, was subjected to allele specific oligonucleotide dot blot analysis, restriction fragment length polymorphism analysis or DNA sequencing. Polymorphism of the TNF gene to NcoI did not correlate with Type 1 diabetes in Japanese patients. DQwl.2 had a protective effect against the disease, the DQAI*I allele was significantly decreased and DQAI*3 allele was significantly increased. Seventeen out of twenty-two Type i diabetic patients (77%) were homozygous for DQAI*3 and five out of twenty-two (23%) heterozygous. The DQAI*3 gene of Type 1 diabetic patients had a normal nucleotide sequence. Furthermore, DQAI*3 was found unexpectedly in two patients without DR4 or DR9. These data indicate that DQA1 gene confers susceptibility and resistance to Type i diabetes in Japanese subjects.
Type 1 (insulin-dependent) diabetes mellitus is considered to be an autoimmune disease. Several genetic factors contribute to the pathogenesis of Type 1 diabetes, and human leucocyte antigen (HLA) genes are of great importance in occurrence of the disease. Recent studies at DNA level have shown that aspartic acid (Asp) at position 57 of the HLA-DQ~ chain protects against Type 1 diabetes and non-aspartic acid (non-Asp) at the same position predisposes to the disease in Caucasians [1] . Recently however, we have proved that about half the Japanese Type i diabetic patients are homozygous for Asp at this position [2] . This finding indicates that firstly, other genetic markers such as the TNF gene should be explored in Japanese Type 1 diabetic patients and secondly, DQA1 gene should also be examined in relation to the antigen presenting function of the DQ (o~-~) molecule. Thus, we have investigated HLA-DQA1, DQB1 and TNF genes in Japanese subjects.
Subjects and methods

Patients and controls
Twenty-two unrelated Type i diabetic patients attending the Second Department of Internal Medicine of Osaka University Medical School Hospital were studied. All patients were diagnosed clinically according to the criteria of WHO and were on insulin therapy. Thirty-two control subjects were randomly selected from our staff. Informed consent was obtained from all patients and healthy control subjects. This work was performed in accordance with the principles of the Declaration of Helsinki. Serological HLA typing was done by the NIH microlymphocytotoxicity test.
Polymerase chain reaction (PCR )
Genomic DNA was extracted from peripheral lymphocytes and about one microgram was subjected to PCR using 2.5 units of Taq DNA polymerase (AmpliTaq, Perkin-Elmer/Cetus, Norwalk, Ct., USA). Reaction conditions were performed as per the manufacturer's recommendations. Amplification was performed by 30 cycles of denaturation (94 ~ annealing (60 ~ and polymerization (72 ~ Oligonucleotides were synthesized by a DNA synthesizer (Model 381A, Applied Biosystems, Inc., Foster City, Calif., USA). TNFP1 (5'-GCACAGCAGGTGAGGCTCTCC-3') and TNFP2 (5'-GGTGGTGCCACACACCCTI'GG-3') were used as PCR primers for TNF gene amplification. DQAP1
(5'-GCCTCTTACGGTGTAAACTTG-Y) and DQAP2 (5'-ATTGG-TAGCAGCGGTAGAGTT-Y) were used for HLA-DQA1 gene amplification. HLA-DQB1 was amplified using DQP1 and DQP2 as reported previously [2] . [3] . DNA fragment (497 base pairs; bp) including this polymorphic site was amplified and one tenth of the reaction mixture was digested with 10 units of NcoI (Takara shuzo, Kyoto, Japan) for 3 h at 37 ~ The digested sample was subjected to 2% agarose-gel electrophoresis and stained with ethidium bromide. Amplified HLA-DQA1 gene was digested with HaeIII and DdeI. Digested fragments were detected as described above. HLA-D QA1 genotyping (DQAI*I, *2, *3 and *4) was decided by the RFLP patterns as described in detail by Maeda et al. [4] . In brief, HaeIII digestion of DQAI*I, *2, *3, *4 yields 44 + 76 + 117bp, 44 + 190bp, 237bp and 44 + 190bp, respectively. DQAI*2 and *4 can be classified by DdeI (DQAI*2; 98 + 136bp, DQAI*4; 107 + 127bp). HLA-DQB1 genotyping was decided using ASO probes (DQI.1, DQ1.2, DQ1.9, DQ1.AZH, DQ3.1, DQ3.2, DQ3.1-26, DQ3.3-26, DQ4 and DQ2 (5'-GCTGGGGCTGCCTGCCG-3')) [2] . DQwl.12 was identified using DQ1.9 and DQ3.1-26 probes. Hybridization and washing conditions are described elsewhere [2] .
PCR-RFLP and PCR-ASO methods
DNA sequencing
Amplified DNA fragments were isolated after separation by 8% polyacrylamide gel electrophoresis and subcloned to the HincII site of pUC119 vector. M13 universal primers and PCR primers were used as sequencing primers in dideoxy methods. To exclude the PCR errors, three to six individual clones were sequenced following the WHO Nomenclature Committee recommendation.
Statistical analysis
The statistical differences were assessed by Fisher's exact test and the calculation was performed using SAS statistical analysis programme.
Results
A portion of TNF~ gene (497 bp) was amplified and these fragments were digested with NcoI. R F L P patterns are shown in Table 1 shows the summary of NcoI polymorphism of TNF[3 gene. There was no difference in frequency of N c o I polymorphism between the Type 1 diabetic patients and control subjects.
This NcoI polymorphic site is located in the first intron of TNF[3 gene [3] . The amplified fragments from three individuals homozygous for L (one control subject and two Type i diabetic patients) were sequenced. A single base transition at NcoI site (from C C A T G G to C C A T G A ) was observed in these three individuals.
H a e I I I digestion of D Q A 1 gene is shown in Figure l B . Polymorphic patterns of homozygosis for A I * I and A1"3 are shown in lanes 1 and 2, and A1 heterogeneity can be analysed by summation of these patterns (lanes 3 and 4) . In lanes 5 and 6, only 237bp fragment was detected. This indicates that these two patients (lanes 5 and 6) were both homozygous for A1"3 although they had neither D R 4 nor D R 9 ( D R l l / 1 3 and DR8/14). A l t h o u g h Table 1 . Frequencies of TNF, HLA-DQA1 and HLA-DQB 1 alleles in Japanese Type 1 (insulin-dependent) diabetic patients (n = 22) and control subjects (n = 32) 1 (2.3) 6 (9.4) L, NcoI negative; b 8, NcoI positive; ~ p < 0.05 (uncorrected); * and ** indicate p < 0.05 and p < 0.01, respectively. Frequencies of DQB1 allele were calculated as follows: when the result of polymerase chain reaction-allele specific oligonucleotide analysis was X/-, X was counted only once unexpected DQA genotypes were also observed in a few control subjects (e. g. DR1/8-DQA1/3) on one allele, such unusual association to DQAI*3 was not found on both alleles in control subjects. Seventeen out of 22 (77%) Type 1 diabetic patients were homozygous for the DQAI*3 allele and 5 out of 22 (23%) were heterozygous. In contrast, only 11 of 32 (34%) control subjects were homozygous for the DQAI*3 allele. All Type i diabetic patients hadDQAl*3 at least on one allele. Frequency of HLA-DQA1 alleles in Japanese Type i diabetic patients and control subjects are shown in the left lower part of Table 1 . A1"3 was significantly increased (p = 0.000"*) and A1"1 was significantly decreased (p = 0.001"*) in Type 1 diabetes mellitus. Decreased frequency of A1"4 was observed in the patients, but was not significant.
To further investigate whether the unique sequence variation in DQAI*3 gene could be observed or not in the Type 1 diabetic patients, amplified DNA fragments from three DR4/DR4, one DRll/13 (lane 5, Fig. 1B ) and one DR8/14 (lane 6, Fig. 1B ) Type 1 diabetic patients were sequenced but the unique sequence was not detected.
Frequencies of DQB1 alleles are also shown on Table 1 . When the result of PCR-ASO analysis was X/-, X was counted only once. Increased frequencies were observed in DQwl.1, DQw8 (DQw3.2), DQw9 (DQw3.3) and DQw4, but they were not significant in this study. On the other hand, DQwl.2 was significantly decreased (p = 0.040*) in Type i diabetes.
Discussion
TNF gene is located in HLA region (class III) and polymorphism of NcoI site in TNF[3 (not TNFcz) has been established [3] . Badenhoop et al. pointed out the increase of the heterozygosity of this site in Caucasian patients [5] . However, as shown in Table 1 , the frequency did not differ between the control subjects and Type 1 patients in our study. Thus, this polymorphism itself seems to have little influence on manifestation of the disease in Japanese. Besides, amplified DNA sequences of the NcoI site negative type in two patients and one control subject were identical to the sequence which was previously published [3] and thus it was not unique to Type I diabetes.
The participation of HLA-DQA1 to Type 1 diabetes has been suggested in Black [6] , Japanese [7] and Caucasian subjects [8] . Particularly in Japanese subjects the increase of DQAI*3 allele and the decrease of DQAI*4 have been reported previously with PCR-ASO methods [7] . PCR-RFLP methods could type the DQA1 allele easily and rapidly with appropriate restriction endonucleases [4] . Moreover, whether the individual is homozygous or heterozygous can be decided by the patterns of digestion. Using this system, our results demonstrated the increase of DQAI*3 allele in Type i diabetic patients. In addition, this study has clearly shown for the first time in Japanese Type i diabetic patients, that the DQAI*I allele was significantly decreased. The frequency of the DQAI*4 allele did not differ significantly between Type 1 diabetic patients and control subjects. So DQAI*I seems to have a protective effect against Type 1 diabetes in Japanese subjects. The DQAI*I gene is in linkage disequilibrium with DR1, 2, w6 and w8 [4] . The decrease of the D QAI* 1 allele in patients may reflect the decrease of DR2 in Type 1 diabetic patients. Sequence analysis revealed that DQAI*3 allelic sequence of Japanese Type 1 diabetic patients is identical to that reported previously [4] . Since DQAI*3 is in linkage disequilibrium with DR4 and DR9 [4] , the high frequency of DQAI*3 may be accounted for by the linkage with DR4 and DR9. However, we noticed two patients who have neither DR4 nor DR9 but were homozygous for DQAI*3 (Fig. 1 B) . Their DQA types were reconfirmed by DNA sequencing. Though the observed patient number is only two and the unexpected association between DQAI*3 and non-DR4 or DR9 was detected on one allele of a few control subjects, our finding suggests the principal role of DQAI*3 gene in susceptibility to the disease. The decreased frequency of the DQAI*I allele and increased frequency of the DQAI*3 allele strongly suggest that HLA-DQAI*I contributes to resistance and A1"3 confers susceptibility to Type1 diabetes in Japanese subjects.
DQB1 alleles were also investigated in a larger number of subjects than our previous report [2] . Increased frequencies were observed in DQwl.1 (non-Asp), DQw8 (non-Asp), DQw9 (Asp) and DQw4 (Asp) in Type 1 diabetes, although they were not significant. DQwl.2 (Asp) was significantly decreased (p = 0.040*) in Japanese patients as Awata et al. reported recently [9] . This protective effect of DQwl.2 was not observed by Todd et al. [7] , who studied Japanese patients who developed the disease under the age of 16 years. The difference in the age of onset may be a possible explanation for the different incidence of DQwl.2, since most of our patients developed the disease at over the age of 16 years.
In this study we have shown the importance of DQAI*3 in Japanese Type i diabetic patients. However, whether the DQAI*3 gene itself or an unknown gene in linkage with DQA1 is responsible remains to be resolved. Recently, a study with I-A transgenic NOD mice [10] indicated the significance of I-Acz (corresponding to human DQa) chain in the development of diabetes. This result supports that DQA1 gene itself is important for genetic susceptibility to Type i diabetes.
Recently DQ molecules consisting of Arg 52 residuebearing ~ chain and non-Asp 57 residue-bearing [3 chain were suggested as being susceptible in Caucasian patients [8] . In Japanese Type i patients, a combination of DQAI*3 (Arg52) c~chain and DQw4 and/or DQw9 (Asp 57) 13 chain is predominant in our study. Although the combination of responsible c~-[3 dimer is different, these data indicate the importance of considering the whole DQ molecule.
Given the fact that class II MHC molecules can present antigens to T cells, three-dimensional configuration of a class II MHC c~-[3 dimer is important for its interaction with antigens as well as to T cell receptors. In this context, future research should investigate the function of a class II MHC cz-[3 dimer to clarify the pathogenic mechanism of Type I diabetes mellitus.
